Phytoestrogens: the complete science-based guide

You have probably already read that a bowl of soy at breakfast or a spoonful of flaxseed could soften hot flashes. You may also have heard the opposite: that soy is supposedly "dangerous" for women who have had breast cancer. Between these two contradictory messages, it is hard to know what to put on your plate. This article takes stock, study by study, of what research has really established about phytoestrogens.

Good news: on these plant molecules, the data are plentiful and often reassuring. They still have to be read correctly, falling neither into excessive enthusiasm nor into unfounded fear.

What are phytoestrogens?

Phytoestrogens are molecules produced by certain plants, whose chemical structure resembles that of estradiol, your main estrogen. This resemblance allows them to bind to the estrogen receptors present in your cells, rather like a slightly different key that still fits into the lock.

But the detail that changes everything is which lock. Your body has two types of estrogen receptor: alpha (ER-α), very present in the breasts and uterus, and beta (ER-β), abundant in bone, blood vessels, the brain and the gut. Now, phytoestrogens bind preferentially to the beta receptor^[1]. Soy genistein, for example, has a markedly stronger affinity for ER-β than for ER-α. It is this selectivity that distinguishes their action from that of synthetic estrogen and that could explain a gentler effect profile.

Another major difference: their potency. A phytoestrogen is hundreds to thousands of times less active than your natural estradiol. So we are talking about subtle modulation, not a hormone treatment in disguise.

The three families and where to find them

Dietary phytoestrogens are grouped into three main families, according to their structure and their source.

Soy isoflavones are the most studied. Flax lignans, for their part, only become truly active after conversion by your gut flora: the bacteria in your colon convert SDG into enterodiol and enterolactone, the true "mammalian lignans" that then circulate in the blood. An intervention study showed that this conversion is dose-dependent: the more ground flaxseed you consume (5 g then 10 g per day), the more urinary enterolactone excretion increases^[5]. Worth remembering: flax has to be ground to be absorbed, since the whole seed passes through the gut intact.

Real effectiveness: what the meta-analyses say

It is on hot flashes that phytoestrogens have been most tested. The results converge on a nuanced message: a real effect, but a moderate one.

A landmark meta-analysis pooled 19 randomized placebo-controlled trials. It concludes that taking soy isoflavones (median dose of 54 mg per day, in aglycone equivalents) for 6 weeks to 12 months reduces the frequency of hot flashes by about 20.6% and their severity by about 26% compared with placebo^[2]. Interestingly, the supplements richest in genistein were more than twice as effective as the others, which suggests that composition counts as much as the total dose.

A second meta-analysis, published in Maturitas, reaches consistent conclusions: isoflavones provide a statistically significant benefit on hot flashes, while stressing great variability between studies^[3]. In other words, the effect exists, but it does not transform every woman's life in the same way.

An honest clarification is nonetheless needed: what the meta-analyses measure and what the authorities recommend do not coincide. The Afssa report "Safety and benefits of dietary phytoestrogens" (March 2005) concluded that phytoestrogens have little or no effect on hot flashes, stressing the strong placebo effect observed in several trials. And the 2023 position statement of The Menopause Society (formerly NAMS) on non-hormonal treatments of vasomotor symptoms explicitly classifies soy foods, soy extracts and equol among the approaches that are not recommended, for lack of evidence judged consistent from one study to another. An average effect detected in a meta-analysis and a clinical recommendation do not answer the same question.

Why it works for some and not for others: the equol story

The key to this variability lies largely with your gut microbiome. Daidzein, one of the soy isoflavones, can be converted by certain gut bacteria into equol, a metabolite far more active on estrogen receptors. But only 30 to 50% of people host the bacteria capable of producing this equol^[4]. "Equol producers" therefore get more benefit from soy than others.

This discovery inspired trials in which equol is given directly. A randomized, double-blind, placebo-controlled trial conducted in 160 Japanese postmenopausal women who were not equol producers showed that a supplement of 10 mg of natural equol per day for 12 weeks reduced the frequency of hot flashes by nearly 59% (versus 34% on placebo), as well as their severity and certain muscle stiffness^[7]. A promising lead, in particular for those whose flora does not produce equol spontaneously.

Safety: soy and breast cancer, what the cohorts really say

This is the question that worries people most, and rightly so: since phytoestrogens mimic estrogen, might they not "feed" a hormone-dependent cancer? The fear is logical in theory. In practice, the large follow-up studies tell quite a different story.

The most striking study is the Shanghai Breast Cancer Survival Study, a cohort of 5,042 Chinese women who had had breast cancer, followed for nearly 4 years on average. The result: the more soy the women consumed after their diagnosis, the less they died and the less they relapsed. The quarter of women consuming the most soy protein had a risk of death reduced by about 29% and a risk of recurrence reduced by about 32% compared with those consuming the least^[6]. Notably, this favorable association was present both in women with a hormone-dependent tumor and in those without, and in tamoxifen users as well as non-users.

This finding was confirmed by an analysis combining cohorts of American and Chinese women: a consumption of at least 10 mg of isoflavones per day after diagnosis was associated with a significant reduction in the risk of recurrence^[6]. Far from representing a danger, dietary soy therefore appears, at the very least, safe, and probably rather favorable in survivors. The important nuance: these data concern dietary soy (tofu, edamame, soy milk), not necessarily high-dose concentrated supplements, on which caution remains in order and medical advice essential.

What the French and European authorities say

Here, the gap between the cohorts and the official French position deserves to be stated clearly. In its report "Safety and benefits of dietary phytoestrogens" (Afssa, now the Anses, March 2005), the agency holds that an intake of 1 mg of aglycone isoflavones per kilogram of body weight per day presents no particular risk, that is about 60 mg per day for a woman of 60 kg. It recommends that isoflavone-based food supplements carry two statements: "Do not exceed 1 mg/kg body weight per day. Talk to your doctor" and "Not recommended for women with a personal or family history of breast cancer".

That same report identifies the populations in whom caution is explicitly requested: the fetus, infants and children under 3, women with a personal or family history of breast cancer, and people treated for hypothyroidism. It also recommends taking care to limit exposure in utero.

At European level, the 2015 EFSA opinion devoted to isolated isoflavones in food supplements in peri and postmenopausal women found no adverse effect on the breast, the endometrium or the thyroid, at the doses and durations studied in the trials (of the order of 35 to 150 mg per day, over documented durations of up to about two and a half years). But the EFSA sets an explicit limit: its conclusions apply only to postmenopausal women without a current diagnosis or a history of hormone-dependent cancer of the breast or the uterus.

In other words, the two sets of data are not talking about the same thing. The survivor cohorts concern the soy on the plate, in populations that have been eating it since childhood; the official opinions mainly frame concentrated isoflavones in capsules, and exclude from their reassuring conclusions the women concerned by a hormone-dependent cancer. In practice: if you have a personal or family history of breast cancer, isoflavone supplements are officially not recommended for you in France, and the question of dietary soy is settled with your oncologist or your doctor, not with an article.

Practical advice

• Favor whole foods over supplements. Tofu, edamame, tempeh and soy milk provide isoflavones in a complete food matrix. The reassuring studies mainly concern these forms.
• Aim for regularity rather than large amounts. One to two servings of soy a day are enough to approach the doses tested (around 50 mg of isoflavones).
• Grind your flaxseed. One to two tablespoons of ground flax per day, sprinkled on a yogurt or in a smoothie; whole, the seeds do not release their lignans.
• Be patient. The trials show benefits after several weeks, rarely in a few days.
• Do not count on beer for hops. The amounts of prenylflavonoids in it are too small for an effect, and alcohol also worsens hot flashes.
• Do not exceed the official reference value for supplements. The Afssa holds to 1 mg of aglycone isoflavones per kilogram of body weight per day, and requires the label to state the aglycone content. A product that does not state it makes it impossible to know what you are taking.
• Personal or family history of breast cancer: isoflavone supplements are not recommended by the Afssa, and the reassuring conclusions of the EFSA do not apply to you. The same goes for treated hypothyroidism, where caution is requested. Talk to your doctor before taking any concentrated supplement.

Conclusion

Phytoestrogens are neither a miracle cure nor a poison. They are plant molecules with a gentle, selective action, whose moderate but real effect on hot flashes the meta-analyses confirm, particularly in women able to produce equol. On the safety side, the large cohorts of breast cancer survivors are reassuring for dietary soy, while the French authorities advise against isoflavone supplements for women with a personal or family history of breast cancer. Wisdom therefore consists in incorporating them in the form of whole foods, with regularity and without expecting the impossible, in respecting the reference value of 1 mg per kilogram per day if you take a supplement, and in keeping the dialogue open with a health professional for all particular situations.

⚠️ This article is provided for informational and educational purposes only. It does not replace medical advice, diagnosis or treatment. Always consult your doctor or a qualified health professional with any questions about your health.

How we work: our editorial method · Written and verified by Bouchra, editorial lead.